Pharma Sustained Release Excipient Market was valued at USD 5.2 Billion in 2022 and is projected to reach USD 8.5 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The global Pharma Sustained Release Excipient Market was valued at approximately USD 5.2 billion in 2022 and is projected to experience a robust growth trajectory. The market is anticipated to expand at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. This growth is driven by increasing demand for advanced drug delivery systems and the rising prevalence of chronic diseases that require sustained medication. Technological advancements in excipient formulations and the expanding pipeline of sustained release drug products further contribute to this upward trend. As the pharmaceutical industry continues to focus on developing innovative drug delivery solutions, the market for sustained release excipients is poised for substantial growth.
Opportunities within the Pharma Sustained Release Excipient Market are significant, particularly in emerging economies where pharmaceutical infrastructure is rapidly developing. Regions such as Asia-Pacific and Latin America are experiencing increased investment in healthcare and pharmaceutical research, which presents substantial opportunities for market expansion. Additionally, the growing trend towards personalized medicine and the need for patient-centric drug delivery systems are likely to drive demand for sustained release excipients. Emerging markets are expected to contribute significantly to the overall market growth, presenting lucrative opportunities for stakeholders looking to capitalize on the evolving pharmaceutical landscape.
Get an In-Depth Research Analysis of the Global Pharma Sustained Release Excipient Market Size And Forecast [2025-2032]
Teva Pharmaceutical Industries
Mylan N.V.
Valeant Pharmaceuticals International
Pfizer
Sun Pharmaceutical Industries
Novartis AG
AstraZeneca
GlaxoSmithKline
Allergan
Janssen Pharmaceuticals
Mayne Pharma Group
BASF
International Flavors & Fragrances
Ashland Global
Evonik Industries
Croda International
Gattefosse
Merck KGaA
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Pharma Sustained Release Excipient Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Pharma Sustained Release Excipient Market
Pharmaceutical
Health Care
Others
Based on Types the Market is categorized into Below types that held the largest Pharma Sustained Release Excipient market share In 2023.
Gelatin
Polymers
Minerals
Sugars
Chitosan
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pharma Sustained Release Excipient Market Research Analysis
1. Introduction of the Global Pharma Sustained Release Excipient Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Pharma Sustained Release Excipient Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Pharma Sustained Release Excipient Market, By Type
6. Global Pharma Sustained Release Excipient Market, By Application
7. Global Pharma Sustained Release Excipient Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Pharma Sustained Release Excipient Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/